LHCG LHC Group Inc.

LHC Group and CHRISTUS Health Announce Joint Venture Agreement

LHC Group (NASDAQ: LHCG) and CHRISTUS Health today announced entry into a definitive agreement to form a new joint venture to enhance home health, hospice, long-term acute-care services and community-based services across four states. The joint venture will include 21 service locations of CHRISTUS Health, including: seven home health agencies, five hospice programs, two community-based home care services, one inpatient hospice unit, and six long-term acute-care hospitals (LTACH).

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170801006129/en/

It is anticipated that the joint venture agreement will be completed by the end of the third quarter, subject to customary closing conditions, at which time LHC Group will purchase majority ownership of CHRISTUS Health’s home health, hospice, community-based home care services and the LTACH facilities and assume management responsibility. The facilities will continue to operate under their existing names. LHC Group expects annualized revenue from this joint venture of approximately $80 million and that it will not materially affect its 2017 diluted earnings per share.

“CHRISTUS Health is a name widely known and respected throughout the healthcare industry, and we could not be more proud to have them join us in our mission to expand quality healthcare services,” said Keith G. Myers, LHC Group’s chairman and CEO. “Like LHC Group, they have earned their reputation for quality through hard work, dedication to patients, and a commitment to the health of the communities they serve. Working together, we will bring that same level of service to even more people.”

“We’re thrilled to find a strong collaborator who will complement our strengths as a health care leader in the communities we serve,” said Paul Generale, CHRISTUS Continuing Care CEO and CHRISTUS Health’s Executive Vice President, Chief Strategy and Health Network Officer. “We are committed to providing our patients and their families the best quality and compassionate care beyond the doors of our hospitals and clinics and into post-acute settings, including the patient’s home and hospice. In partnering with LHC Group, we’re acting on this commitment and gaining additional expertise and resources.”

Based in Irving, Texas, CHRISTUS Health is an international Catholic, faith-based, not-for-profit health system. The organization operates more than 600 services and facilities, including more than 60 hospitals and long-term care facilities, more than 400 clinics and outpatient centers, and dozens of other health ministries and ventures.

Hospital and home health partnerships focused on delivering patient-centered care in the comfort of the patient’s home are increasingly a key component in helping patients manage their conditions and achieve the best possible health. LHC Group is the joint venture partner of choice. Including CHRISTUS Health, LHC Group is partnered with 75 health systems nationwide consisting of more than 250 hospitals across the United States.

About LHC Group, Inc.

LHC Group, Inc. is a national provider of non-acute healthcare services, providing quality, cost-effective healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice, community-based services agencies and facility-based services. LHC Group operates 311 home health services locations, 87 hospice locations, 11 community-based service locations and six long-term acute care hospitals (LTACHs) with eight locations.

About CHRISTUS Health

CHRISTUS Health, an international Catholic, faith-based, not-for-profit health system, is headquartered in the Dallas area and is comprised of more than 400 services and facilities, including more than 60 hospitals and long-term care facilities, 175 clinics and outpatient centers and dozens of other health ministries and ventures. CHRISTUS services can be found in 60 cities in the U.S., Mexico, Chile and Colombia. The system employs approximately 45,000 Associates and has over 15,000 physicians on facility medical staffs who provide care and support for patients.

EN
01/08/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LHC Group Inc.

LHC GROUP reduces its risk exposure and slightly improves to Neutral

The independent financial analyst theScreener just allocated a lower risk rating to LHC GROUP (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly improved and can be qualified as moderately risky. theScreener considers that these elements merit an overall rating upgrade to Neutral. As of the analysis date April 1, 2022, the closing price was USD 168.13 and its expect...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - D2021 10 12

LPL Financial (LPLA) has created a powerful platform to empower independent and smaller scale wealth advisors to compete with the big players like Merrill Lynch and Morgan Stanley. Uniform Accounting highlights the company's operational improvements that the market is missing, indicating equity upside. AMD Q2 2021 Embedded Expectations Analysis – Market expectations are for Uniform ROA to expand, but management may have concerns about data center revenue growth, EPYC processors, and operating c...

Valens Research
  • Valens Research

LHCG - Embedded Expectations Analysis - 2021 10 11

LHC Group, Inc. (LHCG:USA) currently trades around corporate averages relative to UAFRS-based (Uniform) earnings, with a 24.4x Uniform P/E, implying bullish expectations for the firm. However, management may have concerns about staffing challenges, cost management, and admissions growth. Specifically, management may lack confidence in their ability to gain stronger physician support for taking higher acuity patients into the home, forecast patient volumes and characteristics, and sustain organi...

LHC Group Inc: 1 director

A director at LHC Group Inc sold 5,000 shares at 201.620USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

LHC Group to present at the Baird 2020 Global Healthcare Conference

LHC Group to present at the Baird 2020 Global Healthcare Conference LAFAYETTE, La., Sept. 08, 2020 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020. The presentation will begin at 8:30 a.m. Eastern time, and a live will be available. To access the live webcast, listeners should go to the section of the Company’s website, , approximately 15 minutes prior to the event to register and download any necessary software. About LHC Group, Inc.LHC Group, Inc. is a nat...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch